Next Article in Journal
Sulfated Zirconia-Catalyzed Synthesis of 3,4-Dihydropyrimidin-2(1H)-ones (DHPMs) Under Solventless Conditions: Competitive Multicomponent Biginelli vs. Hantzsch Reactions
Previous Article in Journal
Tungstate Sulfuric Acid (TSA)/ KMnO4 as a Novel Heterogeneous System for Rapid Deoximation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Synthesis of New N-Quaternary-3-benzamidoquinuclidinium Salts

1
Department of Chemistry, Faculty of Natural Sciences, Mathematics and Education, University of Split, N. Tesle 12, 21 000 Split, Croatia
2
Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, Croatia
*
Author to whom correspondence should be addressed.
Molecules 2006, 11(9), 726-730; https://doi.org/10.3390/11090726
Submission received: 28 July 2006 / Revised: 30 August 2006 / Accepted: 21 September 2006 / Published: 28 September 2006

Abstract

:
The synthesis of racemic and enantiomerically pure N-p-methylbenzyl-3- and N-p-chlorobenzylbenzamidoquinuclidinium bromides (6-8 and 9-11, respectively) is described. These compounds were prepared from racemic or enantiomerically pure 3‑benzamidoquinuclidines 3-5 using the appropriate quaternization reagents: p-methyl-benzyl bromide (1) and p-chlorobenzyl bromide (2).

Introduction

Many natural and synthetic quinuclidine derivatives display a wide variety of biological activities and some of them, such as aceclidine, for example, are even commercially available as therapeutic agents [1]. 3-Substitued quinuclidine derivatives have also been shown to be potential antidotes against poisoning by organophosphorus compounds such as pesticides and chemical warfare agents [2,3,4,5,6]. Furthermore, 3-substituted derivatives of quinuclidine such as zacopride and RG 12915 are classical 5‑hydroxytryptamine3 (5-HT3) receptor antagonists [7]. Since 3-substitued quinuclidines contain an asymmetric carbon atom, numerous investigations have concentrated on the resolution of the racemic compounds using chemical [8,9] and biocatalytical [10,11] methods, in order to provide an efficient, simple and inexpensive procedure. In our previous investigations we tested butyrylcholinesterase (BChE) as a possible biocatalyst in the resolution of racemic N-benzyl-3-benzamido- and N-benzyl-3-butanamidoquinuclidinium compounds. The expected resolution by hydrolysis of these amides did not occur, however, we discovered that these enantiomerically pure quaternary derivatives are good inhibitors of the tested enzyme. The best inhibitior of the enzyme was the (S)-enantiomer of N-benzyl-3-benzamidoquinuclidinum bromide, with a Ki = 3.70 ° 0.00 µM, while the corresponding (R)-enantiomer (with a Ki = 25.92 ° 0.01 µM) was a 7-fold weaker inhibitor than the (S)-enantiomer. Both enantiomers of quaternary 3-benzamidoquinuclidines were more potent inhibitors of BChE than enantiomers of quaternary 3-buatanamidoquinuclidines. The (R)-enantiomer of N-benzyl-3-butanamidoquinuclidinium bromide had a Ki value of 159.88 ° 0.47 and its (S)-enantiomer´s Ki was 241.96 ° 0.08 µM, showing that this compound was the weakest inhibitor, 65-fold weaker than the most potent one [12].
In continuation of these studies we present the synthesis of some new derivatives of N-quaternary-3-benzamidoquinuclidine with groups of different chemical and inductive characteristics (CH3 and Cl) introduced at the 4-position of the benzyl ring.

Results and Discussion

Racemic and enantiomerically pure (R)- and (S)-3-benzamidoquinuclidines 3-5 have been synthesized by the reaction of the appropriate 3-aminoquinuclidine and benzoic acid anhydride [12]. Their quaternary salts 6-11 were prepared with p-methylbenzyl bromide and p-chlorobenzyl bromide as the respective quaternization agents (Scheme 1).
Scheme 1.
Scheme 1.
Molecules 11 00726 g001
According to NMR spectroscopy the products were of satisfactory purity and therefore no further purification by recrystallization was necessary. The quaternary bromides were obtained in very good yields. 1H- and 13C-NMR signals of the quinuclidine moiety were completely in an accord with previous data [12]. The assignment of the aromatic benzyl ring 1H- and 13C-NMR signals was based on their chemical shifts and multiplicity (for the 1H signals) and was unambiguously established with the aid of HETCOR data. The attributions of the aromatic 1H-NMR chemical shifts are in full agreement with those previously reported for the N-benzyl-3-benzamidoquinuclidines [12] except that the signal of H-4 is missing due to p-substitution. On the other hand, the aromatic 13C–signals are not in accord with the spectral data of N-benzyl-3-benzamidoquinuclidines [12]. The 13C-chemical shifts of C-3, C-4 and C-5 atoms of the benzyl ring are displayed at higher values because the influence of p-substitution.

Experimental Section

General

Quaternization reagents were obtained from Sigma-Aldrich. Reactions were monitored by thin-layer chromatography using DC-Alufolien Aluminiumoxide 60 F254 (Merck) with 9:1 chloroform-methanol as the eluent. The detection of spots was achieved by UV light and by the reversible absorption of iodine. Melting points were determined in open capillaries using a Büchi B-540 apparatus and are uncorrected. Optical rotations (in degrees) were measured in chloroform on an Schmidt + Haensch Polartronic NH8 automatic polarimeter at ambient temperature. Elemental analyses were performed with a Perkin-Elmer PE 2400 Series II CHNS/O Analyser. FTIR spectra were recorded on a Bruker VECTOR 22 FT-IR spectrometer. All samples were prepared by mixing FTIR-grade KBr (Sigma-Aldrich) with 1% (w/w) salt and grinding to a fine powder. Spectra were recorded over the 400-4000 cm-1 range without baseline corrections. Charasteristic absorptions are given in cm-1. 1H and 13C 1D and 2D (HETCOR) NMR spectra were recorded in CDCl3 solutions on a Bruker AV500 spectrometer (300 MHz) at room temperature. Chemical shifts are reported as δ values in ppm using TMS as an internal standard. Coupling constants (J) are given in Hz.

General procedure for the synthesis of N-quaternary quinuclidinium salts 6-11

To the solution of the appropriate 3-benzamidoquinuclidine (3-5, 0.22 mmol) in dry diethyl ether equimolar amounts of p-methylbenzyl bromide (1) were added at room temperature. The reaction mixture was kept in the dark overnight to obtain a solid. The excess of the solvent was then removed under reduced pressure and the solid was washed several times with dry diethyl ether to give compounds 6-8 as white crystals.
(±)-N-p-Methylbenzyl-3-benzamidoquinuclidinium bromide (6). Yield: 99%; mp: 244.2-245.6°C; IR: 3225, 2960, 1648, 1523, 1306, 716; 1H-NMR δ: 1.75-2.16 (m, 4H, H-5 and H-8), 2.35 (m, 3H, CH3), 2.44-2.56 (m, 1H, H-2), 3.39-3.45 (m, 4H, H-6 and H-7), 3.67-3.74 (m, 2H, H-2 and H-4), 4.54 (s, 2H, CH2Bnl), 4.94-4.98 (m, 1H, H-3), 7.18-7.47 (m, 7H, H-2Bnl, H-3Bnl, H-5Bnl and H-6Bnl, H-3Bz, H-4Bz and H-5Bz), 8.22 (d, J=7.06, 2H, H-2Bz and H-6Bz), 8.80 (d, J=5.89, 1H, CONH); 13C-NMR δ: 18.90 (C-5), 21.25 (CH3), 22.44 (C-8), 25.08 (C-4), 46.12 (C-3), 52.93 (C-6), 54.62 (C-7), 57.63 (C-2), 67.39 (CH2Bnl), 123.05 (C-1Bnl), 128.11 (C-3Bz and C-5Bz), 128.26 (C-2Bnl and C-6Bnl), 130.00 (C-2Bz and C-6Bz), 131.75 (C-4Bz), 132.80 (C-1Bz) 132.86 (C-3Bnl and C-5Bnl), 141.21 (C-4Bnl), 167.80 (C=O) Anal. calcd. for C22H27BrN2O: C 63.61, H 6.55, N 6.74. Found: C 63.76, H 6.67, N 6.81.
(R)-N-p-Methylbenzyl-3-benzamidoquinuclidinium bromide (7). Yield: 99%; mp: 226.8-227°C; Molecules 11 00726 i001‑74° (c=0.41, CHCl3). IR, 1H- and 13C-NMR were identical to those of 6.
(S)-N-p-Methylbenzyl-3-benzamidoquinuclidinium bromide (8). Yield: 98%; mp: 231.4-232.4°C; Molecules 11 00726 i001+76° (c=0.38, CHCl3). IR, 1H- and 13C-NMR were identical to those of 6.
The same reaction procedure as described for 6-8 was followed using p-chlorobenzyl bromide (2) as the other quaternization agent and the appropriate 3-benzamidoquinuclidines 3-5 to give compounds 9-11 as white crystals.
(±)-N-p-Chlorobenzyl-3-benzamidoquinuclidinium bromide (9). Yield: 99%; mp: 250.8-252.3°C; IR: 3224, 2961, 1646, 1523, 1485, 1305, 720; 1H-NMR δ: 1.27-1.29 (m, 1H, H-5), 1.65-1.67 (m, 2H, H-8), 2.02-2.09 (m, 2H, H-4 and H-5), 3.01-3.25 (m, 2H, H-2), 3.27-3.61 (m, 4H, H-6 and H-7), 4.47 (s, 2H, CH2Bnl), 4.60-4.84 (m, 1H, H-3), 7.35-7.55 (m, 7H, H-2Bnl, H-3Bnl, H-5Bnl and H-6Bnl, H-3Bz, H-4Bz and H-5Bz), 8.27 (d, J=6.95, 2H, H-2Bz and H-6Bz), 8.79 (d, J=5.72, 1H, CONH); 13C-NMR δ: 18.90 (C-5), 22.48 (C-8), 24.82 (C-4), 46.16 (C-3), 53.62 (C-6), 54.89 (C-7), 57.76 (C-2), 66.89 (CH2Bnl), 124.36 (C-1Bnl), 128.12 (C-3Bz and C-5Bz), 128.43 (C-2Bnl and C-6Bnl), 129.87 (C-2Bz and C-6Bz), 131.95 (C-4Bz), 132.54 (C-1Bz) 134.28 (C-3Bnl and C-5Bnl), 137.73 (C-4Bnl), 167.91 (C=O) Anal. calcd. for C21H24BrN2O: C 57.88, H 5.55, N 6.43. Found: C 58.39, H 5.83, N 6.61.
(R)-N-p-Chlorobenzyl-3-benzamidoquinuclidinium bromide (10). Yield: 92%; mp: 239.7-241.9°C; Molecules 11 00726 i001-40° (c=0.2, CHCl3); IR, 1H- and 13C-NMR were identical to those of 9.
(S)-N-p-Chlorobenzyl-3-benzamidoquinuclidinium bromide (11). Yield: 99%; mp: 242.3-244.7°C; Molecules 11 00726 i001+40° (c=02, CHCl3); IR, 1H- and 13C-NMR were identical to those of 9.

Acknowledgements

This work was supported by the Ministry of Science, Education and Sports of the Republic of Croatia, Project No. 0119610.

References

  1. Mashkovsky, M.D.; Yakhontov, L.N.; Kaminka, M.E.; Mikhlina, E.E. Further developments in research on the chemistry and pharmacology of synthetic quinuclidine derivatives. Prog. Drug. Res. 1983, 27, 9–61. [Google Scholar]
  2. Sterling, G.H.; Doukas, P.H.; Sheldon, R.J.; O'Neill, J.J. In vivo protection against toxicity by known inhibitors of acetylcholine synthesis in vitro. Biochem. Pharmacol. 1988, 37, 379–384. [Google Scholar]
  3. Sterling, G.H.; Doukas, P.H.; Jackson, C.; Caccese, R.; O'Neill, K.J.; O'Neill, J.J. 3-Carbamyl-N-alylquinuclidinium bromide. Effects on cholinergic activity and protection against soman. Biochem. Pharmacol. 1993, 45, 465–472. [Google Scholar]
  4. Amitai, G.; Balderman, D.; Bruckstein-Davidovici, R.; Spiegelstein, M. US Patent 4,675,326, 1987.
  5. Amitai, G.; Rabinovitz, I.; Zomber, G.; Chen, R.; Cohen, G.; Adani, R.; Raveh, L. Proceedings of the 5th International Symposium On Protection Against Chemical and Biological Warfare Agents; Stockholm, Defence Research Establishment: Umea, Sweden, 1995; pp. 247–254.
  6. Simeon-Rudolf, V.; Reiner, E.; Škrinjarić-Špoljar, M.; Radić, B.; Lucić, A.; Primožič, I.; Tomić, S. Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and effect upon Soman intoxicated mice. Arch. Toxicol. 1998, 72, 289–295. [Google Scholar]
  7. Langlois, M.; Soulier, J.L.; Allainmat, M.; Shen, S.; Gallais, C. Derivatives of quinuclidine as 5-HT3 receptor antagonists: Influence of an additional carbonyl group on the recognition of chirality by the receptor. Bioorg. Med. Chem. Lett. 1993, 3, 1555–1558. [Google Scholar]
  8. Ringdahl, B.; Jope, R.S.; Jeden, D.J. Inhibition of high affinity choline transport by stereoisomers of some 3-quinuclidinol derivatives. Biochem. Pharmacol. 1984, 33, 2819–2822. [Google Scholar] [CrossRef]
  9. Sternbach, L.H.; Kaiser, S. Antispasmodics. II. Esters of Basic Bicyclic Alcohols. J. Am. Chem. Soc. 1952, 74, 2219–2221. [Google Scholar] [CrossRef]
  10. Kalir, A.; Sali, E.; Shirin, E. Preparation of (+)-3-quinuclidinol. Isr. J. Chem. 1971, 9, 267–268. [Google Scholar]
  11. Rehavi, M.; Maayani, S.; Sokolovsky, M. Enzymatic resolution and cholinergic properties of (±) 3-quinuclidinol derivatives. Life Sci. 1977, 21, 1293–1302. [Google Scholar] [CrossRef]
  12. Odžak, R.; Tomić, S. 3-Amidoquinuclidine derivatives: Synthesis of compounds and inhibition of butyrylcholinesterase. Bioorg. Chem. 2006, 34, 90–98. [Google Scholar]
  • Sample Availability: Samples of the compounds are available from authors.

Share and Cite

MDPI and ACS Style

Odzak, R.; Tomic, S. Synthesis of New N-Quaternary-3-benzamidoquinuclidinium Salts. Molecules 2006, 11, 726-730. https://doi.org/10.3390/11090726

AMA Style

Odzak R, Tomic S. Synthesis of New N-Quaternary-3-benzamidoquinuclidinium Salts. Molecules. 2006; 11(9):726-730. https://doi.org/10.3390/11090726

Chicago/Turabian Style

Odzak, Renata, and Srdjanka Tomic. 2006. "Synthesis of New N-Quaternary-3-benzamidoquinuclidinium Salts" Molecules 11, no. 9: 726-730. https://doi.org/10.3390/11090726

Article Metrics

Back to TopTop